PT  - JOURNAL ARTICLE
AU  - Oliveira, Gonçalo
TI  - Refined compartmental models, asymptomatic carriers and COVID-19
AID  - 10.1101/2020.04.14.20065128
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.14.20065128
4099  - http://medrxiv.org/content/early/2020/04/21/2020.04.14.20065128.short
4100  - http://medrxiv.org/content/early/2020/04/21/2020.04.14.20065128.full
AB  - The goal of this article is to analyze some compartmental models specially designed to model the spread of a disease whose transmission has the same features as COVID-19. The major contributions of this article are: (1) Rigorously find sufficient conditions for the outbreak to only have one peak, i.e. for no second wave of infection to form; (2) Investigate the formation of other waves of infection when such conditions are not met; (3) Use numerical simulations to analyze the different roles asymptomatic carriers can have. We also argue that dividing the population into non-interacting groups leads to an effective reduction of the transmission rates.As in any compartmental model, the goal of this article is to provide qualitative understanding rather than exact quantitative predictions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementGonçalo Oliveira is supported by Fundação Serrapilheira 1812-27395, by CNPq grants 428959/2018-0 and 307475/2018-2, and by FAPERJ through the grant Jovem Cientista do Nosso Estado E-26/202.793/2019.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in the preprint.